← FDA Drug Approvals (Drugs@FDA)
SODIUM NITROPRUSSIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2022-08-26
Drug application
- FDA Application #
ANDA215846- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM NITROPRUSSIDE
- Generic name
- SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE
- Active ingredients
- SODIUM NITROPRUSSIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SLATE RUN PHARMA
- Manufacturer
- Slate Run Pharmaceuticals, LLC
- First approval
- 2022-08-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown